A Precision Engineered Interleukin-2 for Bolstering CD8+ T- and NK-cell Activity without Eosinophilia and Vascular Leak Syndrome in Nonhuman Primates.
Ma L, Acuff NV, Joseph IB, Ptacin JL, Caffaro CE, San Jose KM, Aerni HR, Carrio R, Byers AM, Herman RW, Pavlova Y, Pena MJ, Chen DB, Buetz C, Ismaili TK, Pham HV, Cucchetti M, Sassoon I, Koriazova LK, Leveque JA, Shawver LK, Mooney JM, Milla ME.
Ma L, et al. Among authors: pena mj.
Cancer Res Commun. 2024 Oct 1;4(10):2799-2814. doi: 10.1158/2767-9764.CRC-24-0278.
Cancer Res Commun. 2024.
PMID: 39320047
Free PMC article.